These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 3614089

  • 1. Clofazimine for leprosy and Mycobacterium avium complex infections.
    Med Lett Drugs Ther; 1987 Aug 14; 29(746):77-8. PubMed ID: 3614089
    [No Abstract] [Full Text] [Related]

  • 2. Critical comments on the treatment of leprosy and other mycobacterial infections with clofazimine.
    Freerksen E, Seydel JK.
    Arzneimittelforschung; 1992 Oct 14; 42(10):1243-5. PubMed ID: 1472145
    [Abstract] [Full Text] [Related]

  • 3. The pharmacology, metabolism, and chemistry of clofazimine.
    O'Connor R, O'Sullivan JF, O'Kennedy R.
    Drug Metab Rev; 1995 Oct 14; 27(4):591-614. PubMed ID: 8925720
    [No Abstract] [Full Text] [Related]

  • 4. Lamprene (clofazimine) in leprosy. Basic information.
    Yawalkar SJ, Vischer W.
    Lepr Rev; 1979 Jun 14; 50(2):135-44. PubMed ID: 396428
    [No Abstract] [Full Text] [Related]

  • 5. Effect of combined clofazimine and ansamycin therapy on Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS.
    Masur H, Tuazon C, Gill V, Grimes G, Baird B, Fauci AS, Lane HC.
    J Infect Dis; 1987 Jan 14; 155(1):127-9. PubMed ID: 3794396
    [No Abstract] [Full Text] [Related]

  • 6. Clofazimine: a review of its use in leprosy and Mycobacterium avium complex infection.
    Garrelts JC.
    DICP; 1991 May 14; 25(5):525-31. PubMed ID: 2068838
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of effectiveness of clofazimine therapy. I. Monitoring of absorption of clofazimine from gastrointestinal tract.
    Mathur A, Venkatesan K, Bharadwaj VP, Ramu G.
    Indian J Lepr; 1985 May 14; 57(1):146-8. PubMed ID: 3839813
    [Abstract] [Full Text] [Related]

  • 8. Controlled long-term therapy of leprosy with B663 (lamprene, clofazimine) compared with DDS.
    Tolentino JG, Rodriquez JN, Abalos RM.
    Int J Lepr Other Mycobact Dis; 1974 May 14; 42(4):416-418. PubMed ID: 4617720
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of localized Mycobacterium avium complex infection with clofazimine and doxycycline in a cat.
    Kaufman AC, Greene CE, Rakich PM, Weigner DD.
    J Am Vet Med Assoc; 1995 Aug 15; 207(4):457-9. PubMed ID: 7591945
    [Abstract] [Full Text] [Related]

  • 10. Clofazimine: a review of its medical uses and mechanisms of action.
    Arbiser JL, Moschella SL.
    J Am Acad Dermatol; 1995 Feb 15; 32(2 Pt 1):241-7. PubMed ID: 7829710
    [Abstract] [Full Text] [Related]

  • 11. Experiences with clofazimine therapy in leprosy.
    Kundu SK, Hazra SK, Choudhury S, Ghosh S.
    Lepr India; 1976 Oct 15; 48(4 Suppl):695-702. PubMed ID: 1026806
    [No Abstract] [Full Text] [Related]

  • 12. Effects of the administration of B663 [G 30 320, Lamprene, clofazimine (Geigy)] on three groups of lepromatous and borderline of leprosy.
    Rodriguez JN, Abalos RM, Reich CV, Tolentino JG.
    Int J Lepr Other Mycobact Dis; 1974 Oct 15; 42(3):276-88. PubMed ID: 4617715
    [No Abstract] [Full Text] [Related]

  • 13. The antileprotic action of clofazimine (B663, G30, 320, Lamprene).
    Azulay RD, da Silva NC, Zeo A, Portela AB, Franca JC, Peluso LL.
    Int J Lepr Other Mycobact Dis; 1974 Oct 15; 42(1):13-8. PubMed ID: 4607163
    [No Abstract] [Full Text] [Related]

  • 14. Limitations of clofazimine in the treatment of lepra reactions.
    Mishra B, Girdhar BK.
    Indian J Lepr; 1986 Oct 15; 58(1):73-8. PubMed ID: 3746000
    [Abstract] [Full Text] [Related]

  • 15. Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease.
    Selby W, Pavli P, Crotty B, Florin T, Radford-Smith G, Gibson P, Mitchell B, Connell W, Read R, Merrett M, Ee H, Hetzel D, Antibiotics in Crohn's Disease Study Group.
    Gastroenterology; 2007 Jun 15; 132(7):2313-9. PubMed ID: 17570206
    [Abstract] [Full Text] [Related]

  • 16. Metabolism of clofazimine in leprosy patients.
    Feng PC, Fenselau CC, Jacobson RR.
    Drug Metab Dispos; 1981 Jun 15; 9(6):521-4. PubMed ID: 6120809
    [Abstract] [Full Text] [Related]

  • 17. Lamprene (clofazimine) and its side effects.
    Salafia A, Kharkar RD.
    Indian J Lepr; 1987 Jun 15; 59(3):313-4. PubMed ID: 3440850
    [Abstract] [Full Text] [Related]

  • 18. Vitamin A levels of ichthyotic and non-ichthyotic skin and plasma of leprosy patients with and without clofazimine therapy.
    Bharadwaj VP, Sritharan V, Venkatesan K, Girdhar A, Ramu G.
    Indian J Med Res; 1982 Jun 15; 75():773-7. PubMed ID: 7129548
    [No Abstract] [Full Text] [Related]

  • 19. Chemotherapy trial with a triple-drug regimen, including once-monthly Rimactane (Rifampicin), in patients with multibacillary types of leprosy.
    Reyes-Javier PD, Tantiongco PR.
    Acta Leprol; 1983 Jun 15; 1(3):133-41. PubMed ID: 6359801
    [No Abstract] [Full Text] [Related]

  • 20. Clofazimine-resistant leprosy, a case report.
    Warndorff-van Diepen T.
    Int J Lepr Other Mycobact Dis; 1982 Jun 15; 50(2):139-42. PubMed ID: 6749703
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.